Judge Approves $158M Settlement Of J&J Risperdal Suit

Law360, New York (March 27, 2012, 3:56 PM EDT) -- A Texas judge on Tuesday approved a final settlement in which a Johnson & Johnson unit will pay $158 million to end allegations that it illegally marketed antipsychotic drug Risperdal, despite the drugmaker's concerns that the whistleblower who brought the suit would receive too much from the deal.

An attorney for whistleblower and original plaintiff in the complaint Allen Jones disclosed that the state of Texas would receive about 41 percent of the total settlement, the federal government would get about 30 percent, Jones would take...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.